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Objective:  to  investigate  the  prevalence  and  risk  factors  associated  with  wheezing  in  infants
in the  ﬁrst  year  of  life.
Methods: this  was  a  cross-sectional  study,  in  which  a  validated  questionnaire  (Estudio  Interna-
cional de  Sibilancias  en  Lactantes  -  International  Study  of  Wheezing  in  Infants  -  EISL)  was  applied
to  parents  of  infants  aged  between  12  and  15  months  treated  in  26  of  85  primary  health  care
units  in  the  period  between  2006  and  2007.  The  dependent  variable,  wheezing,  was  deﬁned
using  the  following  standards:  occasional  (up  to  two  episodes  of  wheezing)  and  recurrent  (three
or  more  episodes  of  wheezing).  The  independent  variables  were  shown  using  frequency  distri-
bution  to  compare  the  groups.  Measures  of  association  were  based  on  odds  ratio  (OR)  with  a
conﬁdence  interval  of  95%  (95%  CI),  using  bivariate  analysis,  followed  by  multivariate  analysis
(adjusted  OR  [aOR]).
Results: a  total  of  1,029  (37.7%)  infants  had  wheezing  episodes  in  the  ﬁrst  12  months  of  life;  of
these,  16.2%  had  recurrent  wheezing.  Risk  factors  for  wheezing  were  family  history  of  asthma
(OR  =  2.12;  95%  CI:  1.76-2.54)  and  six  or  more  episodes  of  colds  (OR  =  2.38;  95%  CI:  1.91-2.97)  and
pneumonia  (OR  =  3.02;  95%  CI:  2.43-3.76).  For  recurrent  wheezing,  risk  factors  were:  familial
asthma  (aOR  =  1.73;  95%  CI:  1.22--2.46);  early  onset  wheezing  (aOR  =  1.83;  95%  CI:  1.75-3.75);
nocturnal  symptoms  (aOR  =  2.56;  95%  CI:  1.75-3.75),  and  more  than  six  colds  (aOR  =  2.07;  95%
CI  1.43-  .00). Please cite this article as: Bessa OA, Leite ÁJ, Solé D, Mallol J. Prevalence and risk factors associated with wheezing in the ﬁrst year of
ife. J Pediatr (Rio J). 2014;90:190--6.
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Conclusion:  the  main  risk  factors  associated  with  wheezing  in  Fortaleza  were  respiratory  infec-
tions and  family  history  of  asthma.  Knowing  the  risk  factors  for  this  disease  should  be  a  priority
for  public  health,  in  order  to  develop  control  and  treatment  strategies.
© 2013  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  
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Prevalência  e  fatores  de  risco  associados  à  sibilância  no  primeiro  ano  de  vida
Resumo
Objetivo:  veriﬁcar  a  prevalência  e  fatores  de  risco  associados  à  sibilância  em  lactentes  no
primeiro ano  de  vida.
Métodos: estudo  transversal,  onde  foi  aplicado  o  questionário  padronizado  e  validado  (Estudio
Internacional  de  Sibilancias  en  Lactantes-EISL)  aos  pais  de  lactentes  com  idade  entre  12  e
15  meses  que  procuraram  26  das  85  unidades  de  atenc¸ão  básica,  no  período  2006  a  2007.  A
variável  dependente,  sibilância,  foi  deﬁnida  utilizando  os  seguintes  padrões:  ocasional  (até
dois  episódios  de  sibilância)  e  recorrente  (três  ou  mais  episódios).  As  variáveis  independentes
foram  apresentadas  usando  distribuic¸ão  de  frequências,  utilizadas  para  comparar  os  grupos.  As
medidas  de  associac¸ões  foram  baseadas  em  razão  de  chances  (odds  ratio-OR),  com  intervalo  de
conﬁanc¸a de  95%  (IC95%),  com  análise  bivariada,  seguida  de  análise  multivariada  (OR  ajustada).
Resultados:  um  total  de  1.029  (37,7%)  lactentes  apresentou  sibilância  nos  primeiros  12  meses
de vida  e  destes,  16,2%  tiveram  sibilância  recorrente.  Os  principais  fatores  de  risco  associados
à  sibilância  foram:  história  familiar  de  asma  (ORa  =  2,12;  IC95%:  1,76-2,54);  seis  ou  mais  episó-
dios  de  resfriado  (ORa  =  2,38;  IC95%:  1,91-2,97)  e  pneumonia  (ORa  =  3,02;  IC95%:  2,43-3,76)  e
sibilância  recorrente  foram:  asma  na  família  (ORa  =  1,73;  IC95%:  1,22-2,46);  início  precoce  de
sibilância  (ORa  =  1,83;  IC95%:  1,75-3,75);  sintomas  noturnos  (ORa  =  2,56;  IC95%:  1,75-3,75);  mais
de  6  resfriados  (ORa  =  2,07;  IC95%:  1,43-3,00).
Conclusão:  os  principais  fatores  de  risco  associados  à  sibilância  foram  as  infecc¸ões  respiratórias
e história  de  asma  na  família.  Conhecer  os  fatores  de  risco  dessa  enfermidade  deve  ser  uma
prioridade  para  a  saúde  pública,  que  poderá  desenvolver  estratégias  de  controle  e  tratamento.
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Wheezing  is  a  very  common  symptom  in  infants,1 which  is
usually accountable  for  a  high  demand  of  medical  consulta-
tions and  emergency  care  services,  with  relatively  high  rates
of hospitalization.  Along  with  acute  respiratory  infections,
it plays  an  important  role  in  infant  mortality.2 In  Latin  Amer-
ica, approximately  100,000  children  die  in  the  ﬁrst  year  of
life due  to  acute  respiratory  infection,  and  a  signiﬁcant  pro-
portion of  them  have  a  history  of  wheezing.3 In  Brazil,  data
from the  Ministry  of  Health  show  that  around  35%  of  infant
hospitalizations in  the  ﬁrst  year  of  life  in  Brazil  are  due  to
respiratory diseases.4
Nevertheless,  the  real  extent  of  this  problem  remains
unknown, as  well  as  how  many  of  these  infants  are  actu-
ally asthmatic  patients.5 The  factors  that  establish  the  start,
evolution, and  prognosis  of  wheezing  in  infants  have  not  yet
been well  deﬁned.  As  it  occurs  in  older  children,  it  is  likely
that individual  genetic  and  immunological  patterns,  associ-
ated with  environmental  factors,  are  responsible  for  most  of
wheezing phenotypes  in  childhood.6,7 Most  studies  indicate
a multifactorial  etiology  in  the  pathogenesis  of  wheezing  in
the ﬁrst  year  of  life,  in  addition  to  the  close  association
with respiratory  infections.  However,  how  these  different





IThe  International  Study  of  Wheezing  in  Infants  (Estudio
nternacional de  Sibilancias  en  Lactantes  [EISL])  was  devel-
ped in  order  to  determine  the  prevalence  and  risk  factors
ssociated with  wheezing  in  infants  in  the  ﬁrst  year  of  life.10
he  EISL  project  evaluated  the  risk  factors  associated  with
heezing in  the  ﬁrst  year  of  life  in  children  from  Latin
merica, Spain,  and  the  Netherlands.  Data  showed  a  large
ariation in  the  prevalence  and  severity  of  wheezing  at  the
enters, but  with  a  tendency  of  higher  prevalence  and  sever-
ty in  Latin  American  children.  The  present  study  is  part  of
he EISL  project  -  phase  1.
This  study  aimed  to  determine  the  prevalence  and  risk
actors associated  with  wheezing  in  infants  in  the  ﬁrst  year
f life,  living  in  Fortaleza,  Brazil,  using  the  EISL  protocol.
ethods
he  present  study  was  conducted  in  the  city  of  Fortaleza,
apital of  the  state  of  Ceará,  Northeastern  Brazil,  as  part
f the  EISL  project  -  phase  1.10 The  EISL  is  a  cross-sectional,
ulticenter, international  study  with  descriptive  and  analyt-cal elements,  developed  to  assess  the  prevalence,  severity,
nd other  characteristics  of  wheezing  in  infants  in  the  ﬁrst
ear of  life  from  Latin  America,  Spain,  and  the  Netherlands.






































































































ith  other  respiratory  diseases,  especially  pneumonia,  and
o deﬁne  the  risk  factors  for  wheezing  in  infants  in  their
rst 12  months  of  life,  similarly  to  the  ‘‘International  Study
f Asthma  and  Allergies  in  Childhood’’  (ISAAC).11
The  study  was  performed  in  26  of  85  primary  care  units,
elected at  random  and  proportional  to  the  demographic  dis-
ribution in  the  six  regions  (regional  executive  secretariats
RES]) of  Fortaleza.  Each  RES  has  its  unique  characteristics
egarding geographic  location  (coastal  region,  peripheral
egion), distribution  of  income,  territorial  occupation,  and
xtension.12
The  study  population  comprised  infants  aged  between
2 and  15  months,  selected  during  routine  consultations  or
mmunizations. Children  with  chronic  diseases  in  other  sys-
ems who  presented  any  respiratory  impact  (neuropathies,
eart disease,  severe  somatic  malformations  and  genetic
iseases, among  others)  were  excluded.
Data  collection  was  conducted  from  December  of  2006
o December  of  2007  using  the  written  questionnaire  (WQ)
f EISL  as  the  collection  tool,  which  was  standardized  and
alidated for  the  local  environment  (Brazilian  culture)  after
eing translated  into  Brazilian  Portuguese.13 The  WQ-EISL
omprises questions  regarding  demographic  characteristics,
heezing, respiratory  infections,  and  risk  factors,  namely:
ender, age,  ethnicity,  birth  weight  and  height,  current
eight and  height,  type  of  delivery,  maternal  schooling,
haracteristics of  wheezing,  medication  use,  hospitaliza-
ion, association  with  pneumonia,  and  environmental  and
amily factors,  among  others.
The  questions  are  very  sensitive,  and  are  based  on  clinical
ractice as  well  as  on  international  studies  on  infants,  to
nsure comparable  information  on  the  epidemiological  and
linical issues  related  to  this  disease.
The  dependent  variable,  wheezing,  was  deﬁned  in  this
tudy as  the  presence  of  wheezing  or  bronchitis  in  the  ﬁrst
2 months  of  the  child’s  life,  and  categorized  as  occa-
ional (up  to  two  episodes  of  wheezing)  or  recurrent  (three
r more  episodes  of  wheezing).  The  independent  varia-
les (exposure)  were  grouped  according  to  demographic,
ocioeconomic, environmental,  family,  and  clinical  charac-
eristics.
ata  analysis
ata  were  organized  in  a  standard  format;  data  entry  was
erformed using  EPI  INFO,  version  3.5.1,  and  data  analysis
as conducted  using  STATA,  version  10.  The  variables  were
hown using  the  distribution  of  frequencies  and  Pearson’s
hi-squared test  was  used  to  compare  groups  of  infants.
easures of  association  were  based  on  odds  ratio  (OR)  with  a
5% conﬁdence  interval  (95%  CI),  with  bivariate  analysis  fol-
owed  by  multivariate  analysis  (logistic  regression-adjusted
R). In  the  univariate  analysis,  the  association  between  each
xplanatory variable  and  the  dependent  variable  (wheezing)
as investigated  separately,  which  was  used  as  a  selection
riterion for  the  independent  variables  used  in  the  ﬁnal
odel. Then,  these  variables  were  included  in  the  logisticegression model  (adjusted  OR),  which  evaluated  the  effect
f the  selected  variables  on  the  outcome.  In  this  case,  the
nﬂuence of  each  explanatory  variable  was  controlled  by  the
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The study  was  approved  by  the  Ethics  Committees  of
he Universidade  Federal  do  Ceará  (No.  734/06  and  COMEPE
rotocol 238/06)  and  of  the  Universidade  Federal  de  São
aulo (No.  0804/09),  in  accordance  with  the  Declaration  of
elsinki. The  research  protocol  was  approved  by  the  Health
ecretariat of  Fortaleza.  Voluntary  and  anonymous  partici-
ation was  guaranteed  by  the  informed  consent  given  before
he interviews.
esults
he  study  included  2,732  infants,  of  whom  1,024  (37.7%)
ad wheezing  episodes  in  the  ﬁrst  12  months  of  life;  16.2%
f these  had  recurrent  wheezing,  with  three  or  more  crises
n the  ﬁrst  year  of  life.
Around 57%  of  the  wheezing  infants  were  males,  and
0% were  of  black  or  mixed-race  ethnicity.  The  mothers  of
hese infants  had  low  educational  level,  70%  had  no  paid
ork, 18%  were  smokers,  and  13%  smoked  during  preg-
ancy. The  wheezing  infants  had  twice  the  incidence  of
amily history  of  asthma  when  compared  to  non-wheezing
nfants, and  three  times  greater  history  of  colds  and  pneu-
onia. Table  1  shows  the  comparative  analysis  of  wheezers
nd non-wheezers  according  to  the  demographic,  socioeco-
omic, environmental,  family,  and  clinical  characteristics  of
he study  population.
Recurrent  wheezers  had  more  severe  symptoms,  noc-
urnal symptoms,  and  visits  to  emergency  rooms  and
ospitalizations for  wheezing  and  pneumonia,  when  com-
ared to  infants  with  occasional  wheezing.  Around  60%  of
ecurrent wheezers  had  the  ﬁrst  crisis  of  wheezing  before  4
onths of  age,  41.9%  had  over  six  episodes  of  colds  in  the
rst year  of  life,  36.3%  had  pneumonia  in  the  ﬁrst  year  of
ife, and  50.9%  had  a  family  history  of  asthma  (Table  2).
The  comparative  analysis  between  the  groups  identiﬁed
everal isolated  factors  that  were  then  evaluated  separately
egarding the  outcome  (wheezing).  The  univariate  analy-
is identiﬁed  possible  risk  and  protective  factors.  Then,  the
ndependent variables  were  selected  to  constitute  the  logis-
ic regression  model  (adjusted  OR),  in  order  to  control  and
liminate possible  confounding  variables.
There  was  an  association  of  wheezing  with  male  gender,
ow maternal  education,  family  history  of  asthma  and  der-
atitis, mold  in  the  household,  and  maternal  smoking  during
nd after  pregnancy.  There  was  also  a  signiﬁcant  association
f wheezing  with  dermatitis  and  high  number  (six  or  more)  of
old and  pneumonia  episodes  in  the  ﬁrst  year  of  life.  Mater-
al breastfeeding  lasting  less  than  four  months  was  also  a
isk factor,  as  shown  in  Fig.  1.
The  main  risk  factors  associated  with  recurrent  wheezing
ere familial  asthma,  early  onset  of  wheezing,  nocturnal
ymptoms, over  six  episodes  of  colds,  asthma  diagnosis,  and
evere symptoms  (Fig.  2).
iscussion
any  studies  worldwide  have  observed  a  high  prevalence
f wheezing  during  the  ﬁrst  years  of  life.  The  ﬁrst  inter-
ational comparison  of  EISL14 studied  over  30,000  children
rom 17  centers  in  Europe  and  Latin  America,  including  eight
n Brazil.  The  recently  published  data  demonstrated  that
Prevalence  and  risk  factors  associated  with  wheezing  in  the  ﬁrst  year  of  life  193
Table  1  Comparative  analysis  between  wheezers  and  non-wheezers  in  the  ﬁrst  year  of  life,  according  to  the  demographic,
socioeconomic,  family,  and  clinical  characteristics.
Variables  Wheezer  1,024  (37.66%)  n  (%)  Non-wheezers  1,703  (62.34%)  n  (%)  pa
Gender
Male  586  (57.2)  889  (52.2)
Female  439  (42.7)  814  (47.8)  0.009
Birth  weight  (kg)  3.259  kg  (SD  =  0.6)  3.256  kg  (SD  =  0.6)  -
Current  weight  (kg)  10.5  kg  (SD  =  0.1)  10.3  kg  (SD  =  1.4)  -
Birth  height 49.4  cm  (SD  =  2.6)  49.4  (SD  =  2.4)  -
Current  height 75.2 (SD  =  3.4) 75.8  (SD  =  3.5) -
Start of  wheezing  (months) 4.7 (SD  =  3) -  -
Ethnicity  0.831
White  423  (41.1)  693  (40.7)
Black  601  (58.4)  1006  (59.1)
Asian  5  (0.5)  4  (0.2)
Maternal  schooling 0.073
Elementary  school 463 (45.0) 762 (44.7)
Incomplete  high  school 346 (33.6) 526 (44.7)
Complete  high  school  and
college/university
220 (21.4) 415 (24.4)
Three  or  more  siblings  66  (6.4)  111  (6.5)  0.915
Five  or  more  persons  in  the
household
516 (50.15)  831  (48.8)  0.494
Paid  work  (mother)  247  (24.0)  468  (27.5)  0.045
Attends  daycare  37  (3.6)  61  (3.6)  0.985
Mold  in  the  household  330  (32.1)  497  (29.2)  0.112
Air  pollution  751  (73.0)  1,229  (72.1)  0.643
Smokers  in  the  household  540  (52.7)  751  (52.8)  <  0.0001
Mother  is  a  smoker  187  (18.2)  221  (13.0)  <  0.0001
Mother  smoked  during  pregnancy  134  (13.0)  120  (7.0)  <  0.0001
Pet  in  the  household  (currently)  679  (74.2)  1,263  (65.0)  <  0.0001
Kitchen  in  the  household  1204  (70.7)  805  (78.2)  <  0.0001
Cell  phone  in  the  household  455  (44.2)  541  (31.8)  <  0.0001
Updated  vaccination  schedule  1024  (100)  1,625  (95.4)  0.312
C-section  delivery  432  (42.2)  730  (42.9)  0.724
Early  weaning
(Breastfeeding  for  less  than  four
months)
450  (43.7)  1,087  (63.8)  <  0.0001
Family  history  of  asthma  431  (41.9)  366  (21.5)  <  0.0001
Family  history  of  rhinitis  436  (42.6)  571  (33.5)  <  0.0001
Family  history  of  dermatitis 186 (18.2)  179  (10.5)  <  0.0001
Atopic  dermatitis  604  (59.0)  811  (47.6)  <  0.0001
Six  or  more  colds  282  (27.4)  184  (10.8)  <  0.0001
Age  at  start  of  colds  <  4  months  456  (44.5)  611  (35.9)  <  0.0001
Pneumonia  310  (30.3)  180  (10.6)  <  0.0001






a p-value (Pearson’s chi-squared test).
there  is  a  great  variability  in  the  prevalence  and  severity
of wheezing  in  the  different  centers,  but  with  a  tendency
to higher  prevalence  and  severity  in  children  from  Latin
America.
The prevalence  of  wheezing  in  that  study,  consider-
ing the  total  study  population,  was  45.2%,  20.3%  of  which
corresponded to  recurrent  wheezing.  When  the  data  was
stratiﬁed for  Latin  America,  the  prevalence  was  47.3%  and
21.4% for  wheezing  and  recurrent  wheezing,  respectively,
a
s
wnd  for  Europe,  34.4%,  and  15.0%,  respectively.14 In  Brazil,
he prevalence  of  wheezing  in  the  ﬁrst  year  of  life  ranged
etween 43%  and  63.6%,  and  21.9%  and  36.6%  for  occasional
nd recurrent  wheezing,  respectively.  The  values  observed
ere show  great  variability;  this  difference  is  possibly  associ-
ted with  differences  in  climatological,  environmental,  and
ocioeconomic characteristics  of  different  regions.14
This  study  observed  a  prevalence  of  37.7%  for  occasional
heezing and  16.2%  for  recurrent  wheezing;  this  prevalence
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Table  2  Comparison  between  infants  that  are  occasional  and  recurrent  wheezers,  according  to  the  clinical  features  and  family
history.
Variables  Occasional  wheezer
< three  crises  n  =  580  (%)
Recurrent wheezer  ≥
three crises  n  =  444  (%)
pa
Male  gender  309  (53.3)  277  (37.6)  0.003
Pneumonia  149  (25.7)  161  (36.3)  <  0.0001
Hospitalization  due  to  pneumonia 79  (13.6) 92  (20.7)  0.003
Hospitalization  due  to  bronchitis 29  (5) 165  (37.6) <0.0001
Passive smoking 307  (52.9) 233  (52.5) 0.885
Maternal smoking  92  (15.9)  95  (21.4)  0.024
Mother  smoked  during  pregnancy  68  (11.7)  66  (14.9)  0.140
History  of  asthma  in  the  family  205  (35.3)  226  (50.9)  <  0.0001
History  of  rhinitis  in  the  family  255  (43.9)  181  (40.8)  0.305
History  of  dermatitis  in  the  family  98  (16.9)  88  (19.8)  0.229
Dermatitis  331  (57.1)  273  (61.5)  0.154
Six  or  more  colds  96  (16.5)  186  (41.9)  <  0.0001
Age  at  start  of  colds  <  4  months  204  (35.2)  252  (56.8)  <  0.0001
Age  of  wheezing  <  4  months  182  (37.7)  238  (60.7)  <  0.0001
Updated  vaccination  schedule  580  (100)  444  (100)  0.451
C-section  delivery  244  (42.1)  188  (42.3)  0.930
Use  of  bronchodilator  461  (82.6)  371  (85.3)  0.257
Use  of  inhaled  corticoids  120  (23.7)  89  (22.9)  0.786
Use  of  antileukotrienes  23  (4.9)  10  (2.9)  0.152
Visits  to  the  emergency  room  360  (62.1)  346  (77.9)  <  0.0001
Severe  episodes  374  (47.2)  278  (62.6)  <  0.0001
Hospitalization  due  to  wheezing  75  (12.9)  117  (26.3)  <  0.0001
Diagnosis  of  asthma  59  (10.2)  91  (20.5)  <  0.0001
Frequent  nocturnal  symptoms  930  (16.0)  185  (41.7)  <  0.0001













ca p-value (Pearson’s chi-squared test).
f  recurrent  wheezing  is  below  that  found  in  other  studies
sing the  EISL  protocol,10 especially  in  Brazil.
The  identiﬁcation  of  the  determinants  of  wheezing  in
nfants has  been  the  subject  of  several  studies.  In  fact,
everal factors  appear  to  play  a  decisive  role  in  the
riggering and  maintenance  of  wheezing  in  infants,  such
s genetic,  immunological,  and  environmental  variables,
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Figure  1  Factors  associated  with  wheezing  in  thThis  study  showed  a  signiﬁcant  association  of  wheez-
ng with  respiratory  infection  for  all  types  of  wheezing.
espiratory infections  are  common  in  childhood  and  have
n important  role  in  infant  morbimortality.  They  require
everal outpatient  clinic  visits,  hospital  admissions,  and
onsequently increase  public  health  care  costs  in  many
ountries.15 There  appears  to  be  an  important  association
etween respiratory  infections,  particularly  those  caused  by
iruses, and  the  pathogenesis  of  wheezing  in  childhood.16,17
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The  EISL  showed  a  signiﬁcant  association  between  the
occurrence of  colds  in  the  ﬁrst  three  months  of  life  and
wheezing in  infants  in  countries  from  Europe  and  Latin  Amer-
ica, especially  those  with  recurrent  wheezing.18
Other  factors  also  contribute  to  the  risk  of  wheezing.  In
this study,  a  correlation  was  observed  between  wheezing
and low  maternal  education,  male  gender,  family  history  of
asthma, and  dermatitis.  Several  studies  indicate  genetics
as a  determinant  factor  for  allergic  diseases.19,20 The  EISL
demonstrated a  statistically  signiﬁcant  association  between
wheezing and  factors  such  as  family  history  of  asthma  and
rhinitis.18 It  also  showed  the  association  of  wheezing  with
the male  gender,  especially  in  European  countries  when
compared to  Latin  America.18 The  male  gender  has  been
identiﬁed as  a  risk  factor  for  wheezing  during  the  ﬁrst  years
of life  in  several  studies.21
Other  factors  also  contribute  to  the  risk  of  wheezing  in
infants. In  this  study,  early  weaning,  deﬁned  as  maternal
breastfeeding lasting  less  than  four  months,  appeared  as  a
risk factor.  Breastfeeding  is  widely  promoted  as  an  important
factor in  reducing  the  risk  for  atopy  and  asthma;  however,
the evidence  for  this  effect  is  still  very  conﬂicted.22
A  prospective  study  performed  in  New  Zealand  with
approximately 1,000  children  indicated  that  breastfeeding
is not  a  protective  factor  and  may  even  increase  the  risk  for
atopy.23 Other  studies,  in  contrast,  have  demonstrated  that
exclusive breastfeeding  has  a  signiﬁcant  protective  effect
against the  development  of  recurrent  wheezing,  asthma,
and atopy.  However,  this  protective  effect  appears  to  be
mediated by  nutrients  and  individual  protection  mechanisms
and, to  a  lesser  extent,  to  factors  related  to  atopy.24
This  study  demonstrated  an  association  between  wheez-
ing and  maternal  smoking  during  and  after  pregnancy.  The
harmful effects  of  smoking  on  children’s  health  are  well
known, but  their  potential  impact  on  early  lung  develop-
ment is  less  clear.25 It  is  difﬁcult  to  separate  the  effects  of
i
rre-  and  postnatal  exposure,  as  most  women  who  continue
o smoke  during  pregnancy  (approximately  30%  worldwide)
o not  stop  the  habit  after  the  child  is  born26
However,  assessments  conducted  before  any  postnatal
xposure have  shown  signiﬁcant  changes  in  lung  function
n newborns  whose  mothers  smoked  during  pregnancy,  and
he persistence  of  tobacco  exposure  in  the  postnatal  period
robably increases  the  risk  of  respiratory  diseases.27 A  study
onducted in  Spain  with  over  20,000  children  and  adoles-
ents demonstrated  that  environmental  tobacco  smoke  is
ssociated with  a  higher  prevalence  of  asthma  symptoms,
articularly if  the  mother  or  both  parents  smoke.28
In  the  present  study,  infants  with  recurrent  wheezing
pisodes had  early-onset  wheezing,  severe  episodes,  dif-
culty breathing,  nocturnal  symptoms,  family  history  of
sthma, and  a  medical  diagnosis  of  asthma.  The  EISL  found
imilar results,  especially  in  Latin  American  countries18 and
n Brazilian  cities.29
Some  potential  limitations  of  this  study  were  identiﬁed,
uch as  the  very  homogeneous  study  population  (mostly  low-
ncome) and  its  cross-sectional  design,  which  could  possibly
nﬂuence the  results.  In  addition,  interviews  with  parents
r caregivers  about  events  that  occurred  during  the  infants’
rst year  of  life  may  depend  on  the  ability  of  respondents
o recall  facts,  especially  regarding  questions  that  contain
 high  degree  of  subjectivity,  such  as  the  those  related  to
amily history.
Another important  possible  limitation  was  the  evalua-
ion of  outcomes  (wheezing)  in  this  study,  which  was  based
n information  collected  during  interviews  rather  than  on
edical records.  However,  the  fact  that  the  present  study
s multicenter  and  that  all  the  data  come  from  different
ational and  international  centers  may  minimize  these  lim-
tations.
In summary,  this  study  demonstrated  a  prevalence  of
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hose  found  in  other  studies  using  the  EISL  protocol,  espe-
ially in  Brazil.  It  also  evidenced  a  strong  association  of
heezing with  a  history  of  respiratory  infections,  asthma,
nd atopic  dermatitis  in  the  family.  Moreover,  it  demon-
trated that  infants  with  over  three  episodes  of  wheezing
ad difﬁculty  breathing,  severe  episodes,  nocturnal  symp-
oms, and  a  medical  diagnosis  of  asthma.
This  study  indicates  a  multifactorial  pathogenesis  of
heezing in  the  ﬁrst  year  of  life,  which  is  closely  related
o respiratory  infections.Considering  that  many  cases  of
sthma present  the  initial  symptoms  early  in  the  ﬁrst  year
f life,  it  should  be  a  priority  of  public  health  policy  to  know
he prevalence  and  risk  factors  of  this  disease,  in  order  to
evelop control  and  treatment  strategies  that  impact  on
orbidity and  mortality  of  these  diseases,  and  improve  the
uality of  life  of  these  children  and  their  families.
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